Graduate Teaching Faculty
Graduate Teaching Faculty and Their Research Interests
| Faculty Name | Research Interests |
|---|---|
| Cory Abate–Shen | Understanding the relationship between the processes that control normal development and those that lead to cancer |
| Swarnali Acharyya | Exploring mechanisms of drug resistance and cancer metastasis, with primary focus on metastatic breast cancer and lung cancer |
| Edmund Au | Mechanisms of cortical interneuron circuit assembly and interneuron dysfunction in mental illness |
| Dritan Agalliu | Signaling pathways and molecular mechanisms of CNS angiogenesis and blood-brain barrier formation in the developing CNS. Cell biological mechanisms of blood-brain barrier disruption in CNS pathologies. |
| Rando Allikmets | Stargardt macular dystrophy and other retinal diseases |
| Ottavio Arrancio | Mechanisms underlying changes of synaptic function associated with cognitive impairment |
| Richard Axel | Defining the logic of olfactory perception |
| Richard Baer | The pathogenesis of hereditary breast cancer |
| Jonathan Barasch | Developmental and cell biology of kidney organogenesis |
| Francesca Bartolini | The role of microtubule stability and its regulation in neurodegenerative disease |
| J. Chloe Bulinski | Function of the cytoskeleton during the cell cycle and during differentiation |
| Julie C. Canman | Molecular mechanisms of cell division |
| Peter D. Canoll | Mechanisms of glioma growth and invasion |
| Alejandro Chavez | Our lab aims to expedite the global scientific enterprise through innovative technologies. Our group has a primary focus within the neurodegenerative disease space, but also engages in productive collaborations with outside fields (e.g. microbial biology, cancer biology and laboratory assisted evolution) and will continue to seek exciting opportunities where we can leverage our tools and insight to address important questions |
| Lorraine N. Clark | Genetics of neurodegenerative disease |
| Piero Dalerba | Application of single-cell technologies for the analysis of tissue cell composition. Identification and clinical development of novel predictive biomarkers to guide therapeutic algorithm design in human colon and breast cancer |
| Riccardo Dalla-Favera | Molecular genetics of cancer; molecular pathogenesis of lymphoma and leukemia |
| Thomas Diacovo | Role of PI3Ks in immune function and leukemia |
| Patricia Ducy | Endocrine crosstalks between the skeleton, the brain and the pancreas |
| Karen Duff | Mouse models of Alzheimer’s Disease |
| Dieter Egli | The generation of therapeutically relevant cells for diabetes |
| Ellen Ezratty | Function of primary cilia in tissue stem cells |
| Qing R. Fan | Structural biology; cell surface receptor-ligand recognition |
| Adolfo Ferrando | Understand the molecular mechanisms that sustain the proliferation and survival of leukemic cells, and to identify novel therapeutic targets for the design of highly effective, molecularly-tailored antileukemic drugs |
| Kevin Gardner | Epigenetic regulation in breast cancer |
| Jean Gautier | Better understand the molecular mechanisms responsible for the maintenance of genome stability |
| Amin Ghabrial | Regulation of tube morphogenesis using novel optogenetic tools, as well as the further elaboration of the CCM3/GckIII pathway. |
| Lloyd A. Greene | Molecular mechanisms governing neuronal differentiation and survival |
| Wei Gu | P53 in tumor suppression and aging |
| Gregg G. Gundersen | The regulation and function of the microtubule cytoskeleton |
| Rebecca A. Haeusler | Understand the development of pro-atherogenic metabolic abnormalities in the natural history of diabetes and the metabolic syndrome |
| Erin Heinzen | Epilepsy Genetics and Genomics |
| Ulrich Hengst | The physiological role of intra-axonal protein synthesis |
| Eldad A. Hod | Translational research focusing on the effect of modulating iron status on innate immune mechanisms |
| Antonio Iavarone | Molecular genetics of tumors derived from the nervous system |
| Un Jung Kang | 1) Understanding the mechanisms of dopaminergic therapy to maximize its efficacy; 2) Understanding the mechanisms of neurodegeneration in Parkinson's disease (PD) to gain insights for potential neuroprotective therapies |
| Tae-Wan Kim | Presenilin biology and molecular mechanism of Alzheimer's disease |
| Stavroula Kousteni | Molecular studies of skeletal physiology |
| Anna Lasorella | Molecular biology of pediatric tumors |
| Roger Lefort | Molecular mechanisms of neurodegeneration and synaptotoxicity in Alzheimer’s disease |
| Oren Levy | Studying cell death pathways involved in Parkinson's disease, using cellular and animal models |
| Fangming Lin | 1) Stem cell-based therapy to accelerate renal repair following acute kidney injury. 2) Mechanisms of renal tubular atrophy after urinary tract obstruction. |
| Ronald Liem | The neuronal cytoskeleton and its involvement in neurodegenerative diseases |
| W. Ian Lipkin | Immunopathogenesis and infectious diseases |
| Jeremy J. Mao | Stem Cells; biomaterials; wound healing; tissue engineering |
| Carol A. Mason | Molecular mechanisms of axon guidance and synaptogenesis |
| Cathy Mendelsohn | Molecular pathways controlling development of urogenital tract |
| George Z. Mentis | Developmental organization of motor neuronal circuitry Spinal Muscular Atrophy |
| Umrao Monani | Motor neuron disease - spinal muscular atrophy as a paradigm |
| Siddharta Mukherjee | Understanding malignant and pre-malignant blood diseases such as Myelodysplastic Sydrome (MDS) and Acute Myelogenous Leukemia (AML) |
| Kenneth P. Olive | Preclinical therapeutics in genetically engineered mouse models of pancreatic cancer |
| David M. Owens | The contributions of stem cells and differentiated cells to epidermal cancer |
| Utpal Pajvani | The role of developmental pathways, specifically Notch signaling, in obesity-induced metabolic disease, with emphasis on the pathophysiology of Type 2 Diabetes (T2D) and Non-alcoholic Fatty Liver Disease (NAFLD) |
| Laura Pasqualucci | Elucidating the genetic basis of mature B cell malignancies, with emphasis on the two most common subtypes, diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) |
| Livio Pellizzoni | RNA Biology and Motor Neuron Pathology |
| Liza A. Pon | Cytosketetal control of organelle movements and segregation during cell division |
| Serge Przedbrodski | Toxin-induced damage to neurotransmitter systems pertinent to movement disorders |
| Li Qiang | Posttranslational modifications (PTMs) of transcription factors in the pathophysiology of diabetes and obesity, and their associated comorbidities, including hepatic steatosis, cancer and cardiovascular diseases |
| Jianwen Que | Molecular and cellular mechanisms controlling proliferation and differentiation of stem/progenitor cells |
| Kevin A. Roth | Neurotransmitter and Neurotrophin Receptors and Cell Signaling; CNS Cancer Biology and Treatment; Neurodegeneration and Neurodegenerative Disorders |
| Ismael Santa-Maria Perez | Understanding the mechanisms maintaining or altering tau proteostasis in neurons, and their relevance in aging and Alzheimer's disease |
| Michael L. Shelanski | Role of cytoskeleton, cell cycle machinery, and proteases in neuronal degeneration |
| Markus D. Siegelin | Targeting apoptosis in glioblastoma; Identification of novel drug combination therapies for glioblastoma |
| Rae Silver | Sleep-wake cycles and their neural bases, and immune – nervous system interactions in the brain |
| Janet Sparrow | Cell biology of retinal disorders |
| Patrice Spitalnik | Medical Education and Physician Scientist Training; Hematology |
| Steven Spitalnik | The biology of red blood cells |
| Gloria Su | Molecular genetics of head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma |
| Ira Tabas | Cellular and molecular processes related to arterial wall biology and atherogenesis |
| Yvette C. Tanhehco | Cellular therapies for sickle cell disease. Cellular immunotherapies for cancer. Role of apheresis in the treatment of thrombotic microangiopathies. |
| Andrew F. Teich | Synaptic dysfunction in neurodegenerative disease, with an emphasis on Alzheimer's disease |
| Carol Troy | The study of the molecular mechanisms of neuronal death with an emphasis on the regulation of caspase activity |
| Stephen Tsang | Engineering Genome and Metabolome in Patient-specific Stem Cells |
| Richard Vallee | Microtubule motor proteins in axonal transport, brain developmental disease, and synaptic function |
| Clarissa Waites | Roles of protein ubiquitination in synaptic function and neurodegeneration |
| Harris Wang | Understanding the key principles that drive the formation, maintenance, and evolution of genomes within and across microbial populations |
| Hynek Wichterle | The use of stem cells to study the development and function of the nervous system |
| Robert Winchester | Autoimmunity and autoimmune disease |
| Howard J. Worman | The studies of the inner nuclear membrane and its proteins |
| Ai Yamamoto | Protein trafficking in Huntington’s disease and other neurological disorders |
| Darrell Yamashiro | The role of angiogenesis in promoting the growth and metastasis of pediatric solid tumors |
| Andrew Yates | The evolution of immune repertoires throughout an individual's lifespan, and their recovery in HIV-infected individuals following antiretroviral therapy. |
| Lori Zeltser | Developing Circuits Regulating Food Intake and Body Weight |
| Shan Zha | The molecular mechanisms of DNA damage response and their roles in lymphocyte gene-rearrangement |
| Xin Zhang | Investigate the mechanism of cell signaling during eye development |